Cytochromes and cytokines: Changes in drug disposition in animals during an acute phase response: A mini-review

Veterinary Quarterly

Volumn 22, Issue 1, 2000, Pages 17-20

  Monshouwer, M ^a,c   Witkamp, R F ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c PFIZER INC   (United States)

Author keywords

Cytochrome P450; Heme oxygenase; Inflammation; Kupffer cells; Nitric oxide

Indexed keywords

CYTOCHROME; CYTOKINE; DRUG;

ACUTE PHASE RESPONSE; ANIMAL DISEASE; DRUG DISPOSITION; DRUG EFFECT; KUPFFER CELL; NONHUMAN; SHORT SURVEY;

ACUTE-PHASE REACTION; ANIMAL DISEASES; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; NITRIC OXIDE; VACCINATION; VETERINARY DRUGS;

ANIMALIA;

EID: 0033969947     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2000.9695017     Document Type: Review

References (25)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, and Guillouzo A. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Molec Pharmacol 1993; 44: 707–15.
2. Chang KC, Lauer BA, Bell TD, and Chai H. Altered theophylline pharmacokinetics during acute phase respiratory viral illness. Lancet 1978; 1: 1132–33.
3. Chen YL, Le Vraux V, Giroud JP, and Chauvelot-Moachon L. Antitumor necrosis factor properties of non-peptide drugs in acute-phase responses Eur J Pharmacol 1994; 271(2-3): 319–27.
4. Fink-Gremmels J, and Miert ASJPAM van. Veterinary drugs: disposition, biotransformation and risk evaluation. The Analyst 1994; 119: 2521–8.
5. Fukuda Y, and Sassa S. Suppression of cytochrome P4501A1 by interleukin-6 in human HepG2 hepatoma cells. Biochem Pharmacol 1994; 47: 1187–95.
6. Groothuis DG, Miert ASJPAM van, Ziv G, and Nouws JFM. Effects of experimental Escherichia coli endotoxaemia on ampicillin: amoxicillin blood levels after oral and parental administration in calves. J Vet Pharmacol Ther 1978; 1: 81–4.
7. Khatsenko OG, and Kikkawa Y. Nitric Oxide affects constitutive cytochrome P450 isoforms in rat liver. J Pharmacol Exp Ther 1997; 280: 1463–70.
8. Ladefoged O. Pharmacokinetics of antipyrine and trimethoprim in pigs with endotoxin-induced fever. J Vet Pharmacol Ther 1979; 2: 209–14.
9. Leenen FHH, and Miert ASJPAM van. Inhibition of gastric secretion by bacterial lipopolysaccharide in the rat. EurJ Pharmacol 1969; 8: 228–31.
10. Miert ASJPAM van. Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological and therapeutic aspects. Vet Quart 1995; 17: 41–50.
11. Miert ASJPAM van, and Duin CT van. Pharmacological and pathophysiological modulation of food intake and forestomach motility in small ruminants. [Review] J Vet Pharmacol Ther 1998; 21(1): 1–17.
12. Minamiyama Y, Takcmura S, Imaoka S, Funae Y, Tanimoto Y, and Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. J Pharmacol Exp Ther 1997; 283: 1479–85.
13. Monshouwer M, Witkamp RF, Nijmeijer SM, Pijpers A, Verheijden JH, and Miert ASJPAM van. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig. Xenobiotica 1995; 25: 491–9.
14. Monshouwer M, Witkamp RF, Nijmeijer SM, Leengoed LA van, Verheijden JH, and Miert ASJPAM van. Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs. Drug Metab Disp 1995; 23: 44–7.
15. Monshouwer M, McLellan RA, Delaporte E, Witkamp RF, Miert ASJPAM van, and Renton KW. Differential effect of pentoxifylline on lipopolysaccharide induced downregulation of cytochrome P450. Biochem Pharmacol 1996; 52: 1195–1200.
16. Monshouwer M, Witkamp RF, Nijmeijer SM, Amsterdam JG van, and Miert ASJPAM van. Suppression of cytochrome P450-and UDP glucuronosyl transferase dependent enzyme activities by pro-inflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 1996; 137: 237–44.
17. Monshouwer M, Witkamp RF, Nijmeijer SM, Leengoed LA van, Vernooy HC, Verheijden JH, and Miert ASJPAM van. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J Vet Pharmacol Ther 1996; 19: 382–88.
18. Morgan ET. Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol Pharmacol 1989; 36: 699–707.
19. Morgan ET, Thomas KB, Swanson R, Vales T, Hwang J, and Wright K. Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochem Biophys Acta. 1994; 1219 (2): 475–83.
20. Morgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 1997; 29 (4): 1129–88.
21. Pijpers A, Schoevers EJ, Gogh H van, Leengoed LAMG van, Visser IRJ, Miert ASJPAM van, and Verheijden JHM. The influence of disease on feed and water consumption and on pharmacokinetics of orally administered oxytetracycline in pigs. J Animal Sci 1991; 69: 2947–54.
22. Renton KW. Altered theophylline kinetics. Lancet 1978; 2: 160–1.
23. Renton KW, and Armstrong SG. Immune-mediated down regulation of cytochrome P450 and related drug metabolism. In: Immunotoxicology and Immunopharmacology (Second edition, 1994, edited by JH Dean, MI Luster, AE Munson and I Kimber. RavenPress, New York) pp 501–12.
24. Sewer MB, Barclay TB, and Morgan ET. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene. Mol Pharmacol 1998; 54: 273–9.
25. Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshcnaur SC, and Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 1993; 300: 115–23.